December 15, 2025: MDL Created for Ozempic Vision Loss Lawsuits In a significant move, the Judicial Panel on Multidistrict Litigation has approved the creation of a new MDL for Ozempic vision loss lawsuits
This is why people are adverse to taking meds
Besides, China also already has a crowded pipeline of late-stage semaglutide programmes, alongside strong capabilities in drug-delivery devices and vertically integrated factories that can take production from peptides all the way to pens for export
Sporadic use or failure to implement supporting lifestyle changes significantly reduces the supplement's effectiveness and value proposition
"In 'very sad news' for manosphere influencer Clavicular, YouTube bans him"
The FDA has already been building infrastructure to police GLP-1 ingredients, including border measures to prevent certain GLP-1 APIs with quality concerns from entering the supply chain